Lilly signs up to $1.3 billion deal with Superluminal to develop obesity medicines - Reuters

Reuters | Aug. 14, 2025, 9:31 a.m. | Original
Lilly signs up to $1.3 billion deal with Superluminal to develop obesity medicines Reuters
Ulta Beauty and Target plan to conclude partnership in 2026 - Reuters Birkenstock's profit beats estimates on strong footwear demand at full price - Reuters